Evaluating Research Inefficiencies in Randomized Clinical Trials for Endoscopic Resection of Gastrointestinal Lesions: A Cross-Sectional Analysis of ClinicalTrials.gov - Takeaways - MDSpire

Evaluating Research Inefficiencies in Randomized Clinical Trials for Endoscopic Resection of Gastrointestinal Lesions: A Cross-Sectional Analysis of ClinicalTrials.gov

  • By

  • Yun Dai

  • Xue-Ting Li

  • Yong-Shen Zheng

  • Jin-Hai Chen

  • Guo-Xing Xu

  • Hai-Xing Wang

  • December 3, 2025

  • 0 min

Share

  • 1

    Gastrointestinal tumors are prevalent, with early diagnosis significantly improving survival rates compared to advanced-stage lesions.

  • 2

    Randomized clinical trials (RCTs) are crucial for advancing endoscopic resection techniques for early gastrointestinal lesions.

  • 3

    Research waste in RCTs, particularly in surgery, is a major issue, with up to 85.2% of trials experiencing inefficiencies.

  • 4

    The study systematically reviewed RCTs on endoscopic resection to assess research waste and propose improvements for future trials.

  • 5

    Understanding research waste is essential for optimizing clinical trial efficiency and enhancing the translation of findings into practice.

Original Source(s)

Evaluating Research Inefficiencies in Randomized Clinical Trials for Endoscopic Resection of Gastrointestinal Lesions: A Cross-Sectional Analysis of ClinicalTrials.gov

  • by Yun Dai, Xue-Ting Li, Yong-Shen Zheng, Jin-Hai Chen, Guo-Xing Xu, Hai-Xing Wang

  • December 3, 2025

Related Content

Influence of Helicobacter pylori Infection on Gut and Tumor Microbiomes and Its Relationship with Immunotherapy Outcomes in Gastrointestinal Malignancies

Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection

Effects of Malnutrition Assessment via PG-SGA on Clinical Outcomes in Patients with Advanced Gastrointestinal Cancers: A Retrospective Cohort Analysis